UV Light Robot Kills Coronavirus In Two Minutes

Terumo Japan distributor is eyeing broader sales targeting hospital disinfection.

There a machine that’s using UV light in order to disinfect hospitals which has the potential to deactivate the novel coronavirus in just two minutes.

This means that we’re looking at a potentially effective way of removing the virus from the public areas.

A successful test has been recently revealed 

It’s been revealed that the Texas-based Xenex Disinfection Services have recently announced that there’s a successful test of the LightStrike robot against the coronavirus.

This robot is currently sold in Japan by the medical equipment maker Terumo. The robot emits light of wavelengths that are somewhere between 200 and 315 nanometer, and it can decontaminate beds, doorknobs, and more surfaces.

It’s been reported that two to five minutes of ultraviolet radiation are leaving the pathogens too damaged to function.

More than that, it seems that this tech has been already been proven to work against multidrug-resistant bacteria and the Ebola virus as well, says Xenex.

The robot showed 99.99% efficiency in eliminating the coronavirus 

Also, the LightStrike robot has been shown to be 99.99% effective in eliminating the coronavirus from the N95 masks.

This is reducing the risk of reusing the vital protective equipment and it’s extremely important especially considering that there’s a massive global shortage of masks.

The machines have been already introduced in abut 500 health care facilities all over the world.

According to official notes, Terumo was granted exclusive distribution rights in 2017.

It’s also important to note the fact that the devices go from about 15 million yen ($140,000).

These had been deployed in 11 facilities by the end of April, but it seems that the hospitals seeking to avoid spreading the disease have been shoeing increased interest in them.

“Between March and April, we had inquiries from more than 100 medical institutions,” a Terumo representative stated about the issue.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *